Remotely Programmed Deep Brain Stimulation of the Bilateral Subthalamic Nucleus for the Treatment of Primary Parkinson Disease: A Randomized Controlled Trial Investigating the Safety and Efficacy of a Novel Deep Brain Stimulation System
Authors:
- Chencheng ZhangCZChencheng Zhang
- Judith GaultJGJudith Gault
- Wei WangWWWei Wang
- Jianmin LiuJLJianmin Liu
- Ming ShaoMSMing Shao
- Yanyan ZhaoYZYanyan Zhao
- Kristina ZeljicKZKristina Zeljic
- Guodong GaoGGGuodong Gao
- Bomin SunBSBomin Sun
- 2 June 2017
- journal article
- research article
- Published by S. Karger AG in Stereotactic and Functional Neurosurgery
- Vol. 95 (3) , 174-182
Abstract
Background: Deep brain stimulation (DBS) is the most commonly performed surgery for the debilitating symptoms of Parkinson disease (PD). However, DBS systems remain largely unaffordable to patients in developing countries, warranting the development of a safe, economically viable, and functionally comparable alternative. Objective: To investigate the efficacy and safety of wirelessly programmed DBS of bilateral subthalamic nucleus (STN) in patients with primary PD. Methods: Sixty-four patients with primary PD were randomly divided into test and control groups (1:1), where DBS was initiated at either 1 month or 3 months, respectively, after surgery. Safety and efficacy of the treatment were compared between on- and off-medication states 3 months after surgery. Outcome measures included analysis of Unified Parkinson's Disease Rating Scale (UPDRS) scores, duration of “on” periods, and daily equivalent doses of levodopa. All patients were followed up both 6 and 12 months after surgery. Results: Three months after surgery, significant decrease in the UPDRS motor scores were observed for the test group in the off-medication state (25.08 ± 1.00) versus the control group (4.20 ± 1.99). Conclusions: Bilateral wireless programming STN-DBS is safe and effective for patients with primary PD in whom medical management has failed to restore motor function.Keywords
This publication has 21 references indexed in Scilit:
- A Remote and Wireless Deep Brain Stimulation Programming SystemNeuromodulation: Technology at the Neural Interface, 2016
- Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013The Lancet, 2015
- Parkinson's diseaseThe Lancet, 2015
- Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013The Lancet, 2015
- Subthalamic Deep Brain Stimulation With a New Device in Parkinson’s Disease: An Open-Label TrialNeuromodulation: Technology at the Neural Interface, 2013
- Deep Brain Stimulation in China: Present and FutureNeuromodulation: Technology at the Neural Interface, 2012
- Deep Brain Stimulation for Parkinson DiseaseArchives of Neurology, 2011
- Deep brain stimulation plus best medical therapy versus best medical therapy alone for advanced Parkinson's disease (PD SURG trial): a randomised, open-label trialThe Lancet Neurology, 2010
- Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030Neurology, 2007
- The Unified Parkinson's Disease Rating Scale (UPDRS): Status and recommendationsMovement Disorders, 2003